HB1801
1 abstract
Abstract
Phase II randomized clinical trial comparing albumin-bound docetaxel vs. docetaxel in patients with previously treated advanced gastric or gastroesophageal junction adenocarcinoma.Org: Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, China, The Eastern Hospital of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, Tianjin Medical University Cancer Institiute and Hospital, Tianjin, China, Department of VIP Medical Services, Shanxi Province Cancer Hospital, Shanxi, China, Fujian Cancer Hospital, Fuzhou, China, Jilin Cancer Hospital, Changchun, China, Affiliated Cancer Hospital of Harbin Medical University, Harbin, China, Meizhou People's Hospital, Meizhou, China, Hunan Cancer hospital, Changsha, China, Linfen City People's Hospital, Linfen, China, Sichuan Provincial People's Hospital, Chengdu, China, Yunnan Cancer Hospital, Kunming, China, Henan Cancer Hospital, Zhengzhou, China, The First Affiliated Hospital of Xiamen University, Xiamen, China, Gansu Provincial Cancer Hospital, Lanzhou, China, Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China, Changzhi People's Hospital, Changzhi, China, CSPC ZhongQi Pharmaceutical Technology Co., Ltd, Shijiazhuang, China, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, China,